Call us : 1800 103 7100
Mail us : info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Alexion Pharmaceuticals – Daily Digest – AVAFIN

August 3, 2012Transplant Rejectionadmin

Alexion Pharmaceuticals - Daily Digest
AVAFIN
The compound has the potential to treat inflammation associated with chronic disorders like hematology, nephrology, transplant rejection, neurology, and ophthalmology. On the volume side, 3M shares were traded which is greater than the average volume.

and more »

Post navigation

← Organ donation makes grieving easier for one family – WIS Collect only 500 units of blood a day: NACO – Hindustan Times →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Hosted and managed by www.medindindia.net